Stock APGE APOGEE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Apogee Therapeutics, Inc.

Equities

APGE

US03770N1019

Real-time Estimate Cboe BZX
Other stock markets
 03:03:34 2024-05-24 pm EDT 		5-day change 1st Jan Change
47.82 USD +3.88% Intraday chart for Apogee Therapeutics, Inc. -4.81% +71.40%
May. 15 Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases CI
May. 13 Apogee Therapeutics' Q1 Net Loss Widens MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. APGE Stock
  4. Revisions Apogee Therapeutics, Inc.